Wealth Minerals Provides Shareholder Update and Appoints Cesar Jil General Manager for Chile
VANCOUVER, British Columbia, Dec. 17, 2018 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV: WML; OTCQX: […]
VVC Exploration – New Private Placement Financings
TORONTO, Dec. 17, 2018 (GLOBE NEWSWIRE) — VVC Exploration Corporation (“VVC” or the “Company”) (TSX-V:VVC) announces the closing of subscriptions […]
Ackroo Appoints Jason Donville to Board of Directors
Ackroo strengthens Board of Directors with seasoned capital markets and M&A expert OTTAWA, Dec. 17, 2018 (GLOBE NEWSWIRE) — Ackroo […]
Nova LifeStyle Subsidiary iDesign Technology Won Top Microsoft Award in Taiwan Contest
LOS ANGELES, Dec. 17, 2018 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY), a leading U.S.-based, innovative designer and distributor […]
TSX News -
Noranda Income Fund Announces the Special Distribution of 2018 Taxable Income
SALABERRY-DE-VALLEYFIELD, Québec, Dec. 17, 2018 (GLOBE NEWSWIRE) — Noranda Income Fund (TSX: NIF.UN) (the “Fund”) announced today that the Board of […]
FDA Accepts BrainStorm’s NurOwn® IND Application for Progressive Multiple Sclerosis
U.S. Phase 2 Study to Begin in First Quarter of 2019 NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) — BrainStorm […]
REPEAT – Premier Health Announces Binding LOI to Acquire Cloud Practice Inc., a National Medical Software Application Company
Cloud Practice offers cloud-based electronic medical records software applications for physicians throughout Canada As per the latest reported financials, Cloud […]
Dova Pharmaceuticals Announces Management Changes
Dr. David Zaccardelli appointed President and Chief Executive Officer Jason Hoitt appointed Chief Commercial Officer Company provides preliminary estimates of […]
Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis
DUBLIN, Ireland and CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) — Alkermes plc (Nasdaq: ALKS) and Biogen Inc. (Nasdaq: BIIB) today […]
TG Therapeutics, Inc. and Dana-Farber Cancer Institute Announce Publication of Clinical Data from the Phase 1/1b Trial of Umbralisib in Combination with Ibrutinib in Lancet Haematology
NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) and Dana-Farber Cancer Institute today announced the […]
